Infect Control Hosp Epidemiol 2002,23(3):137–140.CrossRefPubMed 4. Kuijper EJ, van Dissel JT, Wilcox MH: Clostridium

difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 2007,20(4):376–383.PubMed 5. Kyne L, Hamel MB, Polavaram R, Kelly CP: Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002,34(3):346–353.CrossRefPubMed 6. Morgan OW, Rodrigues B, Elston T, Verlander NQ, Brown DF, Brazier J, Reacher M: Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 2008,3(3):e1812.CrossRefPubMed 7. Pepin J, Valiquette L, Cossette B: Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a PU-H71 purchase hypervirulent strain in buy MM-102 Quebec. Cmaj 2005,173(9):1037–1042.PubMed 8. Kuijper EJ, Coignard B, Tull P: Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006,12(Suppl 6):2–18.CrossRefPubMed 9. Zilberberg MD, Shorr AF, Kollef MH: Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000–2005. Emerg Infect Dis 2008,14(6):929–931.CrossRefPubMed 10. McDonald LC, Owings M, Jernigan DB: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006,12(3):409–415.PubMed

11.

Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, et al.: A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated FG-4592 datasheet diarrhea with high morbidity and mortality. N Engl J Med 2005,353(23):2442–2449.CrossRefPubMed 12. Hubert B, Loo VG, Bourgault AM, Poirier Miconazole L, Dascal A, Fortin E, Dionne M, Lorange M: A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007,44(2):238–244.CrossRefPubMed 13. anonymous: Deaths involving Clostridium difficle: England and Wales, 1999 and 2001–06. Health Stat Q 2008, (37):52–56. 14. Kuijper EJ, Coignard B, Brazier JS, Suetens C, Drudy D, Wiuff C, Pituch H, Reichert P, Schneider F, Widmer AF, et al.: Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 2007,12(6):E1–2.PubMed 15. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005,353(23):2433–2441.CrossRefPubMed 16. Kuijper EJ, Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A, Kooi T, Hof S, Notermans DW: Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006,12(5):827–830.PubMed 17.